| Net Cash Provided by (Used in) Operating Activities |
542M |
USD |
+586% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
202M |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
1B |
shares |
+100% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
466M |
shares |
+121% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
744M |
USD |
+2314% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
397M |
USD |
+113% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
32.8M |
USD |
-19.4% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
7.69B |
USD |
+130% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
85.4M |
USD |
+76.9% |
Q3 2025 |
Q3 2025 |